Treatment of difficult-to-treat depression - clinical guideline for selected interventions.

Clinical guideline affective disorders persistent depressive disorder refractory depression treatment-resistant depression

Journal

Nordic journal of psychiatry
ISSN: 1502-4725
Titre abrégé: Nord J Psychiatry
Pays: England
ID NLM: 100927567

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 31 8 2021
medline: 5 4 2022
entrez: 30 8 2021
Statut: ppublish

Résumé

Difficult-to-treat-depression (DTD) is a clinical challenge. The interventions that are well-established for DTD are not suitable or effective for all the patients. Therefore, more treatment options are highly warranted. We formulated an evidence-based guideline concerning six interventions not well-established for DTD in Denmark. Selected review questions were formulated according to the PICO principle with specific definitions of the patient population (P), the intervention (I), the comparison (C), and the outcomes of interest (O), and systematic literature searches were performed stepwise for each review question to identify relevant systematic reviews/meta-analyses, and randomized controlled trials. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the methodological quality of the included studies. Clinical recommendations were formulated based on the evidence, the risk-benefit ratio, and perceived patient preferences. We found sufficient evidence for a weak recommendation of repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP). The use of bright light therapy in DTD was not sufficiently supported by the evidence, but should be considered as good clinical practice. The interventions should be considered in addition to ongoing antidepressant treatment. We did not find sufficient evidence to recommend intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation to patients with DTD. The evidence supported two of the six reviewed interventions, however it was generally weak which emphasizes the need for more good quality studies. This guideline does not cover all treatment options and should be regarded as a supplement to relevant DTD-guidelines.

Sections du résumé

BACKGROUND BACKGROUND
Difficult-to-treat-depression (DTD) is a clinical challenge. The interventions that are well-established for DTD are not suitable or effective for all the patients. Therefore, more treatment options are highly warranted. We formulated an evidence-based guideline concerning six interventions not well-established for DTD in Denmark.
METHODS METHODS
Selected review questions were formulated according to the PICO principle with specific definitions of the patient population (P), the intervention (I), the comparison (C), and the outcomes of interest (O), and systematic literature searches were performed stepwise for each review question to identify relevant systematic reviews/meta-analyses, and randomized controlled trials. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the methodological quality of the included studies. Clinical recommendations were formulated based on the evidence, the risk-benefit ratio, and perceived patient preferences.
RESULTS RESULTS
We found sufficient evidence for a weak recommendation of repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP). The use of bright light therapy in DTD was not sufficiently supported by the evidence, but should be considered as good clinical practice. The interventions should be considered in addition to ongoing antidepressant treatment. We did not find sufficient evidence to recommend intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation to patients with DTD.
CONCLUSION CONCLUSIONS
The evidence supported two of the six reviewed interventions, however it was generally weak which emphasizes the need for more good quality studies. This guideline does not cover all treatment options and should be regarded as a supplement to relevant DTD-guidelines.

Identifiants

pubmed: 34455900
doi: 10.1080/08039488.2021.1952303
doi:

Substances chimiques

Antidepressive Agents 0

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

177-188

Auteurs

Stine Bjerrum Moeller (SB)

Psychotherapy Research Unit, Mental Health Centre Stolpegaard, Capital Region Psychiatry, Gentofte, Denmark.
Department of Psychology, University of Southern Denmark, Odense, Denmark.

Krzysztof Gbyl (K)

Center for Neuropsychiatric Depression Research (CNDR), Psychiatric Center Glostrup, Capital Region Psychiatry, Glostrup, Denmark.

Carsten Hjorthøj (C)

Copenhagen Research Center for Mental Health - Core, Mental Health Center Copenhagen, Section of Epidemiology, Department of Public Health, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.

Maike Andreasen (M)

Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.

Stephen F Austin (SF)

Psychiatric Research Unit, Psychiatry Region Zealand, Department of Psychology, University of Southern Denmark, Slagelse, Denmark.

Poul Erik Buchholtz (PE)

Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.

Line Fønss (L)

Center for Neuropsychiatric Depression Research (CNDR), Psychiatric Center Glostrup, Capital Region Psychiatry, Glostrup, Denmark.

Simon Hjerrild (S)

Department for Affective Disorders, Aarhus University Hospital, Aarhus N, Denmark.

Lise Hogervorst (L)

NA, Copenhagen, Denmark.

Martin Balslev Jørgensen (MB)

Mental Health Center Copenhagen, Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Nicolai Ladegaard (N)

Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Psychiatric Centre Copenhagen and Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Klaus Martiny (K)

Sydhavnens Medical Clinic, København, Denmark.

Jonas Meile (J)

Psychiatric Research Unit, Psychiatry Region Zealand, Slagelse, Denmark.

Aake Packness (A)

Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark.
The Royal Danish Library, Aarhus University Library, Health Sciences, Aarhus, Denmark.

Karen Rodriguez Sigaard (KR)

Mood Disorder Clinic, Aarhus University Hospital, Skejby, Denmark.

Krista Straarup (K)

Research and Treatment Program for Bipolar Disorder, Psychiatry, Aalborg University Hospital, Aalborg, Denmark.

Sune P V Straszek (SPV)

Department of Psychiatry, University Clinic, Odense, Denmark.

Claus Havregaard Soerensen (CH)

Mental health Center Psychiatry Vest, Region Zealand Psychiatry, Slagelse, Denmark.

Birgitte Welcher (B)

Mental health Center Psychiatry Vest, Region Zealand Psychiatry, Slagelse, Denmark.

Poul Videbech (P)

Center for Neuropsychiatric Depression Research (CNDR), Psychiatric Center Glostrup, Capital Region Psychiatry, Glostrup, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH